Background and Aim: Endoscopic access to the common bile duct remains difficult in 10% of cases undergoing endoscopic retrograde cholangiopancreatography (ERCP). In the current study, we evaluated the effectiveness of a stiff-shaft and flexible-tip guidewire (Visiglide2 â ) for selective biliary access.
INTRODUCTION

E
NDOSCOPIC RETROGRADE CHOLANGIOPAN-CREATOGRAPHY (ERCP) has become a standard procedure for the treatment of biliary diseases. 1 Cannulation of Vater's papilla during ERCP is mandatory for successful biliary therapy. However, selective biliary cannulation with a standard ERCP catheter or sphincterotome reportedly fails in 15-35% of cases, even in experienced hands. 2, 3 Difficulty in cannulating the biliary ductal system leads to repeated cannulation attempts, resulting in procedure-related adverse events such as post-ERCP pancreatitis and cholangitis. 4 Therefore, developments to ease and shorten the procedure are important.
The guidewire is an essential accessory in ERCP that functions as a support and guide for accessory replacement or insertion during various procedures. Moreover, reports have suggested that use of an appropriate guidewire could increase the success rate of selective cannulation. 5 Wireguided cannulation has been found to increase the primary cannulation rate and reduce the risk of post-ERCP pancreatitis compared to contrast-guided cannulation. 6 Therefore, modifications in guidewire design to optimize performance have been studied and a variety of guidewires is available. Although many characteristics of a guidewire including tip shape, flexibility, stiffness, and hydrophilic coating could influence the success rate of selective biliary cannulation, guidewires with slippery and flexible leading tips are generally accepted as superior for cannulation than stiff and taut wires. However, it remains unclear whether the flexibility of guidewire tips has actually influenced the outcomes of cannulation.
Therefore, we conducted a prospective, randomized, controlled study to evaluate the effectiveness of flexible-tip guidewires for selective biliary cannulation compared with a well-established guidewire in terms of the success rate of biliary cannulation, procedure time, and adverse events.
METHODS
Study design
T
HIS WAS AN open-label, randomized, controlled, single-center trial assessing the value of a novel, flexible-tip guidewire in comparison with a conventional guidewire. Patients were randomly assigned to either the novel guidewire group (group V) or the conventional guidewire group (group C) using computer-generated block randomization and a random number list at the time of ERCP scheduling. The study protocol was approved by the ethics committees of INHA university hospital. ERCP were conducted by one of two experienced endoscopists. On the day of ERCP, medical records of all enrolled patients were evaluated before the procedure in order to complete an assessment form. During the procedure, clinical outcomes including success rate of cannulation, number of papilla attempts to achieve cannulation, number of unintentional pancreatic duct cannulations, cannulation time, and total procedure time were recorded. After the procedure, these outcomes for all patients were also recorded in the assessment form. Blood samples collected 4 h after ERCP were used to determine the occurrence of adverse events, whereas those collected after 24 h were measured to evaluate the clinical outcomes of the procedure.
Definitions
Success of cannulation was defined as completing cannulation with the guidewire and obtaining a cholangiogram within 10 min. If cannulation was not achieved within the 10 min or the guidewire passed into the pancreatic duct more than five times, cannulation was considered to have failed. Cannulation time was defined as from when the endoscopist positioned the endoscope in the duodenal second portion and was ready to cannulate the papilla with the guidewire preloaded inside the papillotome/cannula to obtaining the cholangiogram in patients who achieved selective biliary cannulation with the first guidewire. Total cannulation time was measured using the same method as for cannulation time, but was based on the results of patients who failed biliary cannulation with the first guidewire and achieved cannulation with rescue techniques. Procedure time was defined as the interval between the start of the procedure and removal of the endoscope from the patient. Number of papilla attempts included number of all contacts with the papilla during attempted cannulation, regardless of whether or not the pancreatic duct was cannulated. Postprocedure acute pancreatitis was defined as epigastric pain persisting for at least 24 h and serum amylase level the next morning more than three-fold the normal upper limit according to the 1991 consensus guidelines. 4 
Patients
This study was conducted from October 2015 to September 2016. Consecutive patients over 18 years of age undergoing a diagnostic or therapeutic ERCP who required selective biliary cannulation of the na€ ıve papilla were considered for inclusion. Exclusion criteria were as follows: (i) inability or refusal to give written informed consent; (ii) indication for pancreatic ERCP; (iii) prior history of endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilatation (EPBD); (iv) difficulty in the endoscopic approach (esophageal stenosis, gastric outlet obstruction, and duodenal stenosis); and (v) surgically altered anatomy.
Guidewire
A novel guidewire (0.025-inch diameter, 270-cm length, angled tip, hydrophilic coating; Olympus VisiGlide II â ; Olympus, Japan, Tokyo) was developed to increase the flexibility to assist with cannulating the bile duct. The wire provides optimal flexibility by adding a lengthened tapered core wire at the distal tip and applying a thin hydrophilic coating (Fig. 1) . In addition, the tapered hydrophilic tip provides one-to-one torque control. The conventional guidewire was a hydrophilic guidewire with an angled tip, a length of 260 cm and a diameter of 0.035 inches (Jagwire â ; Boston Scientific, Marlborough, MA, USA).
Endoscopic procedures
All interventions were conducted at Inha University Hospital. All endoscopic procedures in the study were carried out by two experienced biliary endoscopists (J.S.P. and J.S.) who had carried out at least 1000 ERCP procedures prior to the study. Protease inhibitors and rectal indomethacin, which might have affected the occurrence of post-ERCP pancreatitis, were not given before or after ERCP. Before the procedure, midazolam and meperidine hydrochloride were given i.v. for conscious sedation. The procedures were carried out using a conventional side-viewing duodenoscope (TJF-240; Olympus Medical Systems, Tokyo, Japan), and a straight standard injection catheter (ERCP catheter; MTW Endoscopie, D€ usseldorf, Germany) or sphincterotome (CleverCut3V; Olympus Medical Systems). All ERCP procedures were conducted using a guidewire cannulation technique. Selective biliary cannulation was initiated by minimal insertion (2-3 mm) of the catheter or sphincterotome across the ampulla. After minimal insertion, the guidewire was carefully advanced through the common bile duct (CBD) under fluoroscopy until it was seen entering the bile duct. Guidewire manipulations were conducted by an experienced assistant in all cases. In cases of pancreatic duct cannulation, the guidewire was pulled back into a standby position, and attempts were made to redirect it toward the CBD. Such attempts were continued for no longer than 10 min or up to five unintentional cannulations of the pancreatic duct. If biliary cannulation was achieved through guidewire insertion, a cholangiogram was taken with a deep insertion of the catheter or sphincterotome, whereas in the case of failure, a needle-knife papillotomy to access the biliary tree was adopted to minimize the risk of post-ERCP pancreatitis.
Outcome measures
Primary outcome measure was success rate of biliary cannulation. Secondary outcome measures were cannulation time, number of unintentional pancreatic duct cannulations, number of papillary attempts for biliary cannulation, total procedure time, and incidence of adverse events including post-ERCP pancreatitis.
Statistical analysis
Success rate, cannulation time, number of papillary attempts, pancreatic duct cannulation, total procedure time and incidence of adverse events were compared between group V and group C. Continuous variables are presented as means and standard deviations (SD). Categorical variables were compared using the chi-squared test and Fisher's exact test, and quantitative variables were compared using Student's t-test. Logistic regression analysis was used to determine whether the type of guidewire influenced the outcome of biliary cannulation. Odds ratios (OR) and 95% confidence intervals (95% CI) were determined and P < 0.05 was considered to indicate significance. Analyses were conducted using SPSS ver. 19.0 (IMN Co., Armonk, NY, USA).
RESULTS
Baseline characteristics
A TOTAL OF 100 patients were enrolled and randomized in equal numbers to undergo ERCP with either the novel guidewire (group V, n = 50) or the conventional guidewire (group C, n = 50). Baseline characteristics of the Digestive Endoscopy 2018; 30: 245-251
Efficacy of highly flexible-tip wire 247 patients and indications for ERCP are summarized in Table 1 . CBD stones were the most common cause to carry out ERCP. There were no significant differences between groups with regard to age, sex, reason for ERCP, and risk factors associated with the development of post-ERCP pancreatitis. Hematological results including pancreatic enzymes before the procedure also did not differ significantly.
Outcomes of biliary cannulation
Results of cannulations are reported in Table 2 Table 3 ).
Adverse events
Adverse events related to cannulation are summarized in Table 4 . Adverse events related to ERCP were post-ERCP pancreatitis (n = 2, defined as mild by the consensus guidelines), minor bleeding (n = 4), cholangitis (n = 6), and cholecystitis (n = 2). Rates of overall procedure-related adverse events did not differ significantly between groups (P = 0.279). All patients recovered uneventfully in response to conservative treatment and antibiotics. No patients experienced intramural dissection, perforation or severe bleeding.
Failed biliary cannulation cases
Two of 50 patients and seven of 50 patients failed to achieve primary biliary cannulation in group V and group C, respectively. In group V, all had periampullary diverticulum (PAD), and the papilla was located on the lower rim of the PAD. The papilla was identified properly; however, it was difficult to point the guidewire in a suitable direction for biliary cannulation, and the guidewire was passed into the pancreatic duct more than five times in both patients. Of the failed cases in group C, five patients had a tortuous common channel that showed long infundibulum on the endoscopic image (Fig. 2) . Conventional guidewire often did not facilitate passing through the tortuous and long entrance of the bile duct, and resulted in formation of a papillary edema by going through the wrong path in the papilla. The other two failed cases in group C were one patient with duodenal edema, and one with PAD.
DISCUSSION
G ENERALLY, THE TIP of the guidewire is considered the most important part for success in biliary cannulation. 7 Distinctive modification of the novel guidewire is a tapered core wire at the hydrophilic distal tip. This design provides optimal flexibility and improved steerability of the guidewire so that its precise control is possible during delicate endoscopic procedures. Although the success rate of primary biliary cannulation did not differ significantly between group V (96%) and group C (86%; P = 0.08), the success rate had a tendency to be higher in group V than in group C, and the novel guidewire may allow biliary cannulation to be easily achieved based on personal clinical experience. Moreover, the number of papilla attempts was significantly reduced by using the novel guidewire and cannulation time was significantly reduced. When gently Table 4 Adverse events associated with endoscopic retrograde cholangiopancreatography Conventional (n = 50) Novel (n = 50)
P-value
Total no. adverse events, n (%)
10 (20) 4 (8) 0.279 
pushing the guidewire to pass or search the biliary orifice, the hyper-flexible tip could often identify its way in the papilla by itself without resistance. Even if the assistant endoscopist encountered resistance when pushing the guidewire, it frequently passed the biliary orifice by bending of the distal tip without forming a large loop in the guidewire. We expected that adverse events would be minimized by using a novel guidewire because the hyper-flexible distal tip is atraumatic, possibly making it papilla-friendly. However, overall adverse event rates including post-ERCP pancreatitis did not differ significantly between groups. In addition, the rate of adverse events occurrence was relatively lower in the current study than in other studies, especially in case of post-ERCP pancreatitis. 8, 9 The lower adverse event rate would be associated with the clinician's effort to reduce the number of papilla attempts. In the present study, selective biliary cannulation was achieved within two to four papilla attempts in all patients who achieved primary biliary cannulation. In post-ERCP pancreatitis, the rate could increase above 11% after 10 or more attempts. 10 Another reason for the low adverse event rate is that we applied needle-knife papillotomy as the rescue technique in the failed cases according to our study protocol. After unsuccessful cannulation attempts, we stopped attempting to reach the papilla and applied needle-knife papillotomy to achieve biliary cannulation as we strongly believe that avoidance of repeated trauma to the papillary orifice is of utmost importance in biliary cannulation.
Upon analysis of failure cannulation cases, all cases in group V had a PAD. Unintended pancreatic duct cannulations occurred over five times in all cases and rescue techniques were applied. To achieve biliary cannulation in the patients with PAD, specific techniques such as everting the diverticulum using biopsy forceps, saline injection to lift the papilla, or endoscopic clipping of the papillary rim to expose the biliary orifice were frequently required to expose the papillary orifice and align the duct. 11, 12 However, these specific techniques were not applicable according to our protocol; thus, we applied the rescue technique early to expose the bile duct in the visible site. In contrast, the reason for five of seven failure cases in group C was a tortuous common channel. In these cases, guidewires were frequently dislocated and went as far as to generate a loop in the papilla in the guidance of the fluoroscope and papillary edema was frequently noted during the endoscopic procedure; however, the novel guidewire usually passed the papilla relatively smoothly with a bending distal tip. This novel guidewire seemed to be particularly useful in patients with a tortuous common channel to achieve cannulation and to minimize adverse events which are related to endoscopic procedures.
There are some limitations to the present study. First of all, the number of patients was relatively small. Because this study was preliminary, we could not calculate the estimated number of patients to show the efficacy of this novel guidewire compared to the conventional guidewire. Another limitation of the current study is that it was a single-center study. The study population realistically reflected the normal cohort risk in our institution and minimized the risk of variable expertise present in many multicenter studies because all of the ERCP procedures were conducted by experienced endoscopists. Finally, the diameter of the conventional guidewire (0.035 inch) was different from that of the novel guidewire (0.025 inch). Therefore, there is concern that the difference in clinical outcomes would be affected by the different sizes of the guidewire, even though we selected the 0.035-inch guidewire as a control guidewire to show the superiority of the novel guidewire under Figure 2 Representative endoscopic views of cannulation failure cases in which there was a long common channel with a long infundibulum.
generalized conditions. In fact, a recent study of guidewires reported that the 0.025-inch guidewire is able to improve the cannulation rate, and recommended the 0.025-inch guidewire as the first choice in ERCP-related treatment. 13 In this report, authors suggested that the 0.025-inch guidewire could elevate the success rate of cannulation and procedure, or shorten the procedure time compared to the 0.035-inch guidewire because the thinner diameter of the guidewire provided free space within the forceps port. In our clinical experience, we somewhat concurred with the assessment of the 0.025-inch guidewire in the ERCP-related procedure. The 0.025-inch guidewire used in the current study provides sufficient rigidity while it supplies optimal flexibility. Therefore, it is very suitable to achieve cannulation and carry out endoscopic procedure without changing to the 0.035-inch guidewire in order to stabilize the procedure. Therefore, further study with the same thickness of guidewires is required to evaluate the effect of guidewire flexibility in selective biliary cannulation.
In conclusion, the novel guidewire with a highly flexible distal tip showed a tendency to have a higher success rate of biliary cannulation than that of the conventional guidewire. In addition, this guidewire was found to have the ability to improve clinical outcomes of selective biliary cannulation, especially in reducing the number of papilla attempts.
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